Targeted delivery of saporin toxin by monoclonal antibody to the transcobalamin receptor, TCblR/CD320

Molecular Cancer Therapeutics

Volumn 9, Issue 11, 2010, Pages 3033-3040

  Quadros, Edward V ^a   Nakayama, Yasumi ^a   Sequeira, Jeffrey M ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; SAPORIN; TRANSCOBALAMIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL DIVISION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOTOXINS; K562 CELLS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; RIBOSOME INACTIVATING PROTEINS, TYPE 1; TRANSFECTION;

EID: 78649670858     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-10-0513     Document Type: Article

References (19)

1. Takahashi K, Tavassoli M, Jacobsen DW. Receptor binding and internalization of immobilized transcobalamin II by mouse leukaemia cells. Nature 1980;288:713-5.
2. Quadros EV, Nakayama Y, Sequeira JM. The binding properties of the human receptor for the cellular uptake of vitamin B12. Biochem Biophys Res Commun 2005;327:1006-10.
3. Quadros EV. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol;148:195-204.
4. Quadros EV, Nakayama Y, Sequeira JM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin-bound cobalamin. Blood 2009;113:186-92.
5. Hall CA, Colligan PD, Begley JA. Cyclic activity of the receptors of cobalamin bound to transcobalamin II. J Cell Physiol 1987;133:187-91.
6. Lindemans J, Kroes AC, van Geel J, van Kapel J, Schoester M, Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. Exp Cell Res 1989;184:449-60.
7. Amagasaki T, Green R, Jacobsen DW. Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells. Blood 1990;76:1380-6.
8. Wickramasinghe SN. Morphology, biology and biochemistry of cobalamin- and folate-deficient bone marrow cells. Baillieres Clin Haematol 1995;8:441-59.
9. Oldham RK. Monoclonal antibodies in cancer therapy. J Clin Oncol 1983;1:582-90.
10. Frankel AE, Houston LL, Issell BF, Fathman G. Prospects for immunotoxin therapy in cancer. Annu Rev Med 1986;37:125-42.
11. Stirpe F, Gasperi-Campani A, Barbieri L, Falasca A, Abbondanza A, Stevens WA. Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree). Biochem J 1983;216:617-25.
12. Reilly RM, Sandhu J, Alvarez-Diez TM, Gallinger S, Kirsh J, Stern H. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet 1995;28:126-42.
13. Bolognesi A, Polito L, Farini V, et al. CD38 as a target of IB4 mAb carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia. J Biol Regul Homeostatic Agents 2005;19:145-52.
14. Polito L, Bolognesi A, Tazzari PL, et al. The conjugate rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with fludarabine. Leukemia 2004;18:1215-22.
15. Ippoliti R, Lendaro E, D'Agostino I, et al. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity. FASEB J 1995;9:1220-5.
16. Qian ZM, Li H, Sun H, Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002;54:561-87.
17. Daniels TR, Ng PP, Delgado T, et al. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol Cancer Ther 2007;6:2995-3008.
18. Quadros EV, Rothenberg SP, McLoughlin P. Characterization of monoclonal antibodies to epitopes of human transcobalamin II. Biochem Biophys Res Commun 1996;222:149-54.
19. McLean GR, Quadros EV, Rothenberg SP, Morgan AC, Schrader JW, Ziltener HJ. Antibodies to transcobalamin II block in vitro proliferation of leukemic cells. Blood 1997;89:235-42.